ecteinascidin 743 has been researched along with 1-methyltryptophan in 1 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (1-methyltryptophan) | Trials (1-methyltryptophan) | Recent Studies (post-2010) (1-methyltryptophan) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 145 | 4 | 121 |
| Protein | Taxonomy | ecteinascidin 743 (IC50) | 1-methyltryptophan (IC50) |
|---|---|---|---|
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 5.039 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldinucci, D; Borghese, C; Casagrande, N | 1 |
1 review(s) available for ecteinascidin 743 and 1-methyltryptophan
| Article | Year |
|---|---|
Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
Topics: Antibodies, Monoclonal, Humanized; Chemokines; Cytokines; Hodgkin Disease; Immunosuppressive Agents; Killer Cells, Natural; Maraviroc; Nivolumab; Prognosis; Receptors, CCR5; Reed-Sternberg Cells; T-Lymphocytes; Trabectedin; Tryptophan; Tumor Escape; Tumor Microenvironment; Zoledronic Acid | 2019 |